Transcript Nottingham North and East Strategy Medicines Management

Nottingham North and East Strategy
Medicines Management
2014/15
QIPP PLAN Focus for 2014/15
• Quality, Innovation, Productivity & Prevention
• £522k savings to be made on primary care prescribing for 2014/15 for a
£20million budget
• Cost-effective prescribing– occasionally branded products can be more
cost-effective
• Specials
• Asthma Guidelines
• COPD
• Specialist Drugs (Traffic Lights – category Red)
Safety and Quality
• Improving patient safety.
• Maintaining good quality prescribing.
• Monitoring and implementing the Royal College of General Practitioners’
(RCGP) indicators that are rated as valid for assessing the prescribing
safety of individual GPs
• In the first year the team would prioritise those indicators relating to
cardiovascular and respiratory disease and those relating to
musculoskeletal
What can Community Pharmacists do to support this
strategy?
• Nottinghamshire Joint Formulary -useful source of information
• http://www.nottinghamshireformulary.nhs.uk
• Targeted MURs –i.e COPD
• Become familiar with the RCGP indicators
What can Community Pharmacists do to support this
strategy?
• Out of stock medicines – clear communication to practices regarding the
nature of the problem and possibly suggestion suitable alternatives
• Specials/Unlicensed medicines – information to prescribers regarding the
costs of these products and suggest provision of licensed alternatives if
they exist
What can Community Pharmacists do to support this
strategy?
Ensure that patients only receive the medicines that they require. This is an
issue for all CCGs and can lead to issues with
• Safety – patients taking medicines they no longer require
• Waste – poor use of resources and issues regarding disposal of excess
• Financial balance – Less financial resource could lead to a reduction in
services to patients and fewer resources available for contractors and
providers
The Future
• Improvement to services to nursing homes
• Pharmacy First
• Discharge Planning
• MURs and New Medicines Service